| Line Item | 2021-12-31 | Y/Y |
|---|---|---|
| Revenue | $137.6M | +237.4% |
| Cost of Revenue | $108.2M | +231.2% |
| Gross Profit | $29.4M | +262.3% |
| R&D Expense | $4.5M | +124.9% |
| SG&A Expense | $78.7M | +500.6% |
| Operating Income | -$70.2M | -314.2% |
| Interest Expense | $6.5M | +635.5% |
| Pre-tax Income | -$72.8M | -303.7% |
| Income Tax | -$11.3M |
| Line Item | 2021-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $20.5M | +1484.3% |
| Accounts Receivable | $16.3M | +168.5% |
| Inventory | $688K | +108.5% |
| Current Assets | $55.2M | +3629.8% |
| Total Assets | $261.8M | +56.1% |
| Current Liabilities | $51.2M | — |
| Long-term Debt | $77.6M | -0.2% |
| Line Item | 2021-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$37.4M | -138.7% |
| Capital Expenditures | $2.1M | +128.4% |
| Investing Cash Flow | -$38.5M | +54.8% |
| Financing Cash Flow | $74.2M | -39.5% |
| Free Cash Flow | -$39.5M | -138.1% |
| -208.0% |
| Net Income | -$61.5M | -328.1% |
| EPS (Basic) | -$1.36 | -248.7% |
| EPS (Diluted) | -$1.36 | -248.7% |
| Total Liabilities |
| $154.5M |
| +2537.2% |
| Stockholders' Equity | $107.2M | +2044.4% |